Etomidate for intravenous induction of anaesthesia;Medikamente zur intravenösen Narkoseinduktion: Etomidat

Anaesthesist

Volumn 66, Issue 12, 2017, Pages 969-980

  Dumps, C ^a   Bolkenius, D ^a   Halbeck, E ^a  

^a KLINIKUM AUGSBURG   (Germany)

Author keywords

Hypnotics and sedatives; Pharmacodynamics; Pharmacokinetics; Receptors GABA A; Side effects

Indexed keywords

BENZODIAZEPINE; ETOMIDATE; HYPNOTIC AGENT; KETAMINE; MIDAZOLAM; NARCOTIC AGENT; PROPOFOL; THIOPENTAL; HYPNOTIC SEDATIVE AGENT; INTRAVENOUS ANESTHETIC AGENT;

ANESTHESIA INDUCTION; ARTICLE; HEMODYNAMICS; HUMAN; INTRAVENOUS ANESTHESIA;

ANESTHESIA, INTRAVENOUS; ANESTHETICS, INTRAVENOUS; ETOMIDATE; HEMODYNAMICS; HUMANS; HYPNOTICS AND SEDATIVES;

EID: 85034242341     PISSN: 00032417     EISSN: 1432055X     Source Type: Journal    
DOI: 10.1007/s00101-017-0381-6     Document Type: Article

References (54)

1. Duncum BM (1947) The development of inhalation anaesthesia. Royal Society of Medicine Press, London, S 562
2. Petermann H, Goerig M (2016) Geschichte der Anästhesie. Anaesthesist 65:787–808
3. Hudetz AG (2012) General anesthesia and human brain connectivity. Brain Connect 2(6):291–302
4. Eckle VS, Hucklenbruch C, Todorovic SM (2009) Was wissen wir über Narkosemechanismen? Bewusstlosigkeit, Bewegungslosigkeit und Amnesie. Anästhesist 58:1144–1149
5. Schnider JAT (2012) Obligate Maskenbeatmung vor Relaxation. Anaesthesist 61:401–406
6. Committee on Standards and Practice Parameters: Apflebaum JI et al (2013) Practice guidelines for management of the difficult airway. Anesthesiology 118:251–270
7. Rossaint R, Coburn M, Zwissler B (2017) Klug entscheiden in der Anästhesiologie. Dtsch Arztebl 114:22–23
8. Coburn M et al (2016) Qualitätsindikatoren Anästhesiologie 2015. Anasthesiol Intensivmed 57:522–512
9. Mc Clelland SH, Hardman JG (2007) Inhalational induction of anaesthesia in adults: time for a breath of fresh air? Anesthesia 62:1087–1089
10. Jöhr M (2016) Inhalative und intravenöse Anästhesie bei Kindern. Anaesthesist 65:415–422
11. Van Hemelrijk J, Gonzales JM, White PF (1993) Pharmacology of intravenous anesthetic agents. In: Rogers MC, Tinker JH, Covino BG, Longnecker DE (Hrsg) Principles and practice of anesthesiology. Mosby, St. Louis, Baltimore, Boston
12. Medlock RM, Pandit JJ (2016) Intravenous anaesthetic agents. Anaesth Intensive Care Med 17(3):155–162
13. Godefroi EF, Janssen PAJ, Van der Eycken CAM, Van Heertum AHMT, Niemegeers CJE (1965) DL-(1-arylalkyl)imidazole-5-carboxylate esters. A novel type of hypnotic agents. J Med Chem 56:220–223
14. Forman SA (2011) Clinical and molecular pharmacology of etomidate. Anesthesiology 114(3):695–707
15. Kulstad EB, Kalimullah EA, Tekwani KL, Courtney DM (2010) Etomidate as an Induction Agent in septic Patients: red flags or false Alarms? WestJEmergMed 11(2):161–172
16. Kulstad EB, Kalimullah EA, Tekwani KL, Courtney DM (2010) Etomidate as an induction agent in septic patients: red flags or false alarms? West J Emerg Med 11(2):161–172
17. Ledingham IM, Finlay WIE, Watt I et al (1983) Etomidate and adrenocortical function. Lancet 321:1434
18. Ledingham IM, Watt I (1983) Influence of sedation on mortality in critically ill multiple trauma patients. Lancet 321:1270
19. Preziosi P, Vacca M (1982) Etomidate and corticotrophic axis. Arch Int Pharmacodyn Ther 256(2):308–310
20. Rote Liste Service (2015) Fachinformation Etomidate. Rote Liste Service, Frankfurt
21. Tomlin SL, Jenkins A, Lieb WR, Franks NP (1998) Stereoselective effects of etomidate optical isomers on γ‑aminobutyric acid type A receptors and animals. Anesthesiology 88:708–717
22. Evans RH, Hill RG (1978) GABA-mimetic action of etomidate. Experientia 34:1325–1327
23. Uchida I, Kamatchi G, Burt D, Yang J (1995) Etomidate potentiation of GABAA receptor gated current depends on the subunit composition. Neurosci Lett 185:203–206
24. Paris A, Philipp M, Tonner PH, Steinfath M, Lohse M, Scholz J, Hein L (2003) Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate. Anesthesiology 99:889–895
25. Matta JA, Cornett PM, Miyares RL, Abe K, Sahibzada N, Ahern GP (2008) General anesthetics activate a nociceptive ion channel to enhance pain and inflammation. Proc Natl Acad Sci USA 104:8784–8789
26. Rohrsbach CB, Rösslein M (2016) Ist Etomidate out? In: Eckart J, Jaeger K, Möllhoff T (Hrsg) Anästhesiologie, 49. Aufl. ecomed Medizin. C.H. Beck, München
27. Carlos R, Calvo R, Erill S (1979) Plasma protein binding of etomidate in patients with renal failure or hepatic cirrhosis. Clin Pharmacokinet 4:144–148
28. Isitemiz I, Uzman S, Toptas M et al (2014) Prevention of etomidate-induced myoclonus: which is superior: Fentanyl, midazolam, or a combination? A Retrospective comparative study. Medical science monitor. Int Med J Exp Clin Res 20:262–267
29. Doenicke A, Wagner E, Beetz KH (1973) Arterial blood gas analyses following administration of three short-acting i. v. hypnotics (propanidid, etomidate, methohexitone)(authors translation). Anaesthesist 22(8):353–356
30. Nebauer AE, Doenicke A, Hoernecke R, Angster R, Mayer M (1992) Does etomidate cause hemolysis? Br J Anaesth 69(1):58–60
31. Kulka PJ, Bremer F, Schuttler J (1993) Anesthesia induction using etomidate in a lipid emulsion. Anaesthesist 42(4):205–209
32. Pierre StM, Dunkel M, Rutherford A, Hering W (2000) Does etomidate increase postoperative nausea? A double-blind controlled comparison of etomidate in lipid emulsion with propofol for balanced anaesthesia. Eur J Anaesthesiol 17(10):634–641
33. Mayer M, Doenicke A, Neubauer AE, Hepting L (1996) Propofol and etomidate-Lipuro for induction of general anesthesia. Hemodynamics, vascular compatibility, subjective findings and postoperative nausea. Anaesthesist 45(11):1082–1084
34. Diago MC, Amado JA, Otero M, Lopez-Cordovilla JJ (1988) Anti-adrenal action of a subanaesthetic dose of etomidate. Anaesthesia 43:644–645
35. Fragen RJ, Shanks CA, Molteni A, Avram MJ (1984) Effects of etomidate on hormonal responses to surgical stress. Anesthesiology 61(6):652–656
36. Septem Defensiones (1538) Werke Band 2, Darmstadt 1965, Seite 510.
37. Allolio B, Stuttmann R, Leonhard U, Fischer H, Winkelmann H (1984) Adrenocortical suppression by a single induction dose of etomidate. Klin Wochenschr 62:1014–1017
38. Wanscher M, Tonnesen E, Huttel M, Larsen K (1984) Etomidate infusion and adrenocortical function: a study in elective surgery. Acta Anaesthesiol Scand 29:483–485
39. den Brinker M, Hokken-Koelega AC, Hazelzet JA, de Jong FH, Hop WC, Joosten KF (2008) One single dose of etomidate negatively influences adrenocortical performance for at least 24 h in children with meningococcal sepsis. Intensive Care Med 34(1):163–168
40. Absalom A, Pledger D, Kong A (1999) Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anesthesia 54(9):861–867
41. Vinclair M, Broux C, Faure P et al (2008) Duration of adrenal inhibition following a single dose of etomidate in critcally ill patients. Intensive Care Med 34(4):714–719
42. Dörr HG, Kuhnle U, Holthausen H, Bidlingmaier F, Knorr D (1984) Etomidate: a selective adrenocortical 11 beta hydroxylase inhibitor. Klin Wochenschr 62:1011–1013
43. Roumen L, Sanders MP, Pieterse K, Hilbers PA, Plate R, Custers E, de Gooyer M, Smits JF, Beugels I, Emmen J, Ottenheijm HC, Leysen D, Hermans JJ (2007) Construction of 3D models oft he CYP 11B family as a tool to predict ligand binding characteristics. J Comput Aided Mol Des 21:455–471
44. Dewachter P, Mouton-Faivre C, Castells MC, Hepner DL (2011) Anesthesia in the patient with multiple drug allergies: are all allergies the same? Curr Opin Anaesthesiol 24:320–325
45. Cherfan AJ, Arabi YM, Al-Dorzi HM, Kenny LP (2012) Advantages and disadvantages of Etomidate use for Intubation of patients with sepsis. Pharmacotherapy 32(5):475–482
46. Alday NJ, Jones GM, Kimmons LA, Philips GS, McCallister JW, Doepker BA (2014) Effects of etomidate on vasopressor use in patients with sepsis or severe sepsis: a propensity-matched analysis. J Crit Care 29:517–522
47. Dettmer MR, Dellinger RP (2015) The use of etomidate for rapid sequence induction in septic patients. J Thorac Dis 7(10):1684–1686
48. Pejo E, Cotten JF, Kelly EW, Le Ge R, Cuny GD, Laha JK, Liu J, Lin XJ, Raines DE (2012) In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate. Anesth Analg 115:297–304
49. Shanmugasundararaj S, Zhou X, Neunzig J, Bernhardt R, Cotten JF, Ge R, Miller KW, Raines DE (2013) Carboetomidate: an analog of etomidate that interacts weakly with 11β-hydroxylase. Anesth Analg 116(6):1249–1256
50. Cotten JF, Husain SS, Forman SA, Miller KW, Kelly EW, Nguyen HH, Raines DE (2009) Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression. Anesthesiology 111:240–249
51. Cotten JF, Forman SA, Laha JK, Cuny GD, Husain SS, Miller KW, Nguyen HH, Kelly EW, Stewart D, Liu A, Raines DE (2010) Carboetomidate: a Pyrrole analog of Etomidate designed not to suppress adrenocortical function. Anesthesiology 112:637–644
52. Struys MMRF, Valk BI, Eleveld DJ, Absalo AR, Meyer P, Meier S, den Dass I, Chou T, van Amsterdam K, Campagna JA, Sweeney SP (2017) A phase 1. single-center, double-blind, placebo-controlled study in healthy subjects to asses the safety, tolerability, clinical effects, and pharmacokinetics-pharmacodynamics of intravenous cyclopropyl-methoxycarbonylmetomidate (ABP 700) after a single ascending bolus dose. Anesthesiology 127(1):20. https://doi.org/10.1097/ALN.0000000000001662
53. Wang B, Yang J, Chen J, Kang Y, Yang L‑H, Liu J, Zhang W‑S (2017) An Etomidate analogue with less adrenocortical suppression, stable hemodynamics, and improved behavioral recovery in rats. Anesth Analg 125(2):442. https://doi.org/10.1213/ANE.0000000000002063
54. Pejo E, Santer P, Wang L, Dershwitz P, Husain SS, Raines DE (2016) γ-aminobutyric acid type a receptor modulation by etomidate analogs. Anesthesiology 124:651–653